drugset / Trial / NCT05473949

Ketofol Versus Propofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients.

NCT05473949 ↗

RandomizedParallel-groupTriple-blindOther

Summary

This study is a double blind randomized controlled trial. The investigators randomized ASA III and IV patients who underwent cholangiopancreatography. The investigators gave Propofol or Ketofol and compared the outcomes. The primary outcome was security (respiratory depression / hypoventilation).

Timeline

Start
2016-10-01
Primary completion
2017-03-31
Completion
2017-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule — —
Comparator Propofol Small molecule 6 mg/kg —
Comparator Propofol Small molecule 7 mg/kg —

Indications

No indication recorded.